Lorianne Masuoka K. 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Mar 22, 2021
Insider Transaction Report
Form 4
Lorianne Masuoka K.
Director
Transactions
- Award
Stock Option (right to buy)
2021-03-18+5,000→ 5,000 totalExercise: $10.80Exp: 2031-03-17→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]One-third of the shares subject to the option vest on March 18, 2022 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.